Pàgina inicial > Resultats de la cerca: Journal of the American Academy of Dermatology
  Consells de cerca
Cerca simple
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Dipòsit Digital de Documents de la UAB 4 registres trobats  La cerca s'ha fet en 0.02 segons. 
1.
8 p, 789.9 KB Long-term efficacy and safety of brodalumab in the treatment of psoriasis : 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trial / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Lebwohl, Mark (Icahn School of Medicine at Mount Sinai) ; Bachelez, Hervé (AP-HP Hôpital Saint-Louis) ; Sobell, Jeffrey (SkinCare Physicians) ; Jacobson, Abby A. (Ortho Dermatologics) ; Universitat Autònoma de Barcelona
Randomized controlled trials have shown the efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis. To evaluate the efficacy and safety of brodalumab through 120 weeks of treatment in the AMAGINE-2 trial. [...]
2020 - 10.1016/j.jaad.2019.05.095
Journal of the American Academy of Dermatology, Vol. 82 Núm. 2 (february 2020) , p. 352-359  
Registre complet - Creative Commons
2.
10 p, 390.5 KB The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa : Results of a prospective European cohort study / van Straalen, Kelsey R. (Erasmus MC. University Medical Center Rotterdam. Department of Dermatology) ; Tzellos, Thrasyvoulos (Department of Dermatology. Nordland Hospital Trust) ; Guillem, Phillipe (Groupe de Recherche en Proctologie de la Société Nationale Française de ColoProctologie) ; Benhadou, Farida (Department of Dermatology. Université Libre de Bruxelles. Erasme Hospital) ; Cuenca-Barrales, Carlos (TECe19-Clinical and Translational Dermatology Investigation Group Instituto de Investigación Biosanitaria) ; Daxhelet, Mathilde (Department of Dermatology. Université Libre de Bruxelles. Erasme Hospital) ; Daoud, Mathieu (Department of Dermatology. Université Libre de Bruxelles. Erasme Hospital) ; Efthymiou, Ourania (Second Department of Dermatology and Venereology. National and Kapodistrian University of Athens. Medical School. "Attikon" General University Hospital) ; Giamarellos-Bourboulis, Evangelos J. (Fourth Department of Internal Medicine. National and Kapodistrian University of Athens. Medical School) ; Jemec, Gregor B.E. (Department of Dermatology. Zealand University Hospital. Roskilde and Health Sciences Faculty. University of Copenhagen) ; Katoulis, Alexandros C. (Second Department of Dermatology and Venereology. National and Kapodistrian University of Athens. Medical School. "Attikon" General University Hospital) ; Koenig, Anke (Department of Dermatology. Venereology and Allergology. University Hospital Frankfurt am Main) ; Lazaridou, Elizabeth (Second Department of Dermatology and Venereology. Aristotle University of Thessaloniki. General Hospital Papageorgiou) ; Marzano, Angelo V. (Department of Pathophysiology and Transplantation. Università degli Studi di Milano) ; Matusiak, Łucas (Department of Dermatology. Venereology and Allergology. Medical University) ; Molina-Leyva, Alejandro (TECe19-Clinical and Translational Dermatology Investigation Group Instituto de Investigación Biosanitaria) ; Moltrasio, Chiara (Department of Medical Surgical and Health Sciences. University of Trieste) ; Pinter, Andreas (Department of Dermatology. Venereology and Allergology. University Hospital Frankfurt am Main) ; Potenza, Concetta (Dermatology Unit 'Daniele Innocenzi. ' Department of Medical-Surgical Sciences and Biotechnologies. Sapienza University of Rome) ; Romaní, Jorge (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Saunte, Ditte M. (Department of Dermatology. Zealand University Hospital. Roskilde and Health Sciences Faculty. University of Copenhagen) ; Skroza, Nevena (Dermatology Unit 'Daniele Innocenzi. ' Department of Medical-Surgical Sciences and Biotechnologies. Sapienza University of Rome) ; Stergianou, Dimitra (Fourth Department of Internal Medicine. National and Kapodistrian University of Athens. Medical School) ; Szepietowski, Jacek (Department of Dermatology. Venereology and Allergology. Medical University) ; Trigoni, Anastasia (Second Department of Dermatology and Venereology. Aristotle University of Thessaloniki. General Hospital Papageorgiou) ; Vilarrasa-Rull, Eva (Institut d'Investigació Biomèdica Sant Pau) ; van der Zee, Hessel H. (Erasmus MC. University Medical Center Rotterdam. Department of Dermatology) ; Universitat Autònoma de Barcelona
Background: Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current hidradenitis suppurativa guidelines. However, evidence for their efficacy is drawn from small studies, often without validated outcomes. [...]
2021 - 10.1016/j.jaad.2020.12.089
Journal of the American Academy of Dermatology, Vol. 85 Núm. 2 (august 2021) , p. 369-378  
Registre complet - Creative Commons
3.
5 p, 332.3 KB Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment : Results from the CLEAR study / Thaçi, Diamant (Research Institute and Comprehensive Center for Inflammation Medicine. University of Luebeck) ; Puig Sanz, Lluís. (Institut d'Investigació Biomèdica Sant Pau) ; Reich, Kristian (Dermatologikum Berlin and SCIderm Research Institute) ; Tsai, T. F. (National Taiwan University Hospital (Taipei, Taiwan)) ; Tyring, S. (University of Texas Health Science Center and Center for Clinical Studies) ; Kingo, K. (Tartu University Hospital (Tartu, Estònia)) ; Ziv, M. (Emek Medical Center) ; Pinter, A. (Department of Dermatology. University of Frankfurt) ; Vender, Ronald (Venderm Innovations in Psoriasis) ; Lacombe, A. (Novartis Pharma AG) ; Xia, Shang (Novartis Beijing Novartis Pharma Co Ltd) ; Bhosekar, V. (Novartis Healthcare Pvt Ltd) ; Gilloteau, I. (Novartis Pharma AG) ; Guana, A. (Novartis Pharmaceuticals Corporation) ; Blauvelt, Andrew (Oregon Medical Research Center) ; Universitat Autònoma de Barcelona
2019 - 10.1016/j.jaad.2019.04.045
Journal of the American Academy of Dermatology, Vol. 81 Núm. 6 (december 2019) , p. 1405-1409  
Registre complet - Creative Commons
4.
9 p, 310.0 KB Long-term safety and tolerability of apremilast in patients with psoriasis : Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2) / Crowley, Jeffrey (Bakersfield Dermatology) ; Thaçi, Diamant (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; Joly, Pascal (Department of Dermatology, Hôpital Charles Nicolle, Université de Rouen) ; Peris, Ketty (Universitá Cattolica del Sacro Cuore, Roma) ; Papp, Kim A. (Probity Medical Research, Waterloo) ; Gonçalves, Joana (Celgene Corporation) ; Day, Robert M. (Celgene Corporation) ; Chen, Rongdean (Celgene Corporation) ; Shah, Kamal (Celgene Corporation) ; Ferrándiz, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cather, Jennifer C. (Modern Research Associates, Dallas) ; Universitat Autònoma de Barcelona
2017 - 10.1016/j.jaad.2017.01.052
Journal of the American Academy of Dermatology, Vol. 77 Núm. 2 (2017) , p. 310  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem